Healthcare research and the high demand for
food are key areas where next-generation sequencing is being used extensively.
Increasing genetic disorders are being diagnosed which has drastically
increased the demand for next-generation sequencing. Moreover, the use of this
technology in drug discovery is significant and expected to drive growth as the
demand for effective drug therapies increases.
Increasing awareness, employment of various
growth strategies and ongoing technical advancements are expected to provide
the market with ample opportunity for growth. However, the high initial cost of
implementing technologies, and the requirement for storage of large volumes of
data as well as a lack of skilled workforce to run the technology are
challenges to the growth of the Next Generation Sequencing market.
global Next-Generation
Sequencing Market trends is expected to increase value of USD 10300 million
during the projected quarters of 2022-2030, The market is estimated to grow at
11.5% CAGR by 2030. Also known as massive parallel sequencing or high
throughput sequencing technology, next-gen sequencing has been transformative
for the field of genomic research as it allows the sequencing of a complete
human genome in a very short amount of time. During the process, the genetic
material is extracted, fragmented, and associated with various factors for
amplification. As such, this technology is highly effective and advanced thus
driving its adoption and growth. The improved speed and reduced costs are
expected to drive market growth. Use in clinical applications, agricultural
applications, and forensic applications are growing rapidly.
DNA technology has come a long way, and
next generation sequencing is expected to take DNA technology further than ever
before. Market Research Future's report on the global next-generation
sequencing market divulges key details regarding the growth of the market as
well as various vital facts, figures, and prediction of growth of the global
market.
Market Segmentation
Analysis of the markets several parts are
included in MRFR's segmental analysis which has been performed on the basis of
technology, service & product, application, end-user, and region.
The technology used in next-generation
sequencing includes whole exome sequencing, CHIP sequencing, whole genome
sequencing, methyl sequencing, targeted resequencing, de novo sequencing, and
RNA sequencing, next generation sequencing data analysis.
By service & product, the next
generation sequencing market has been segmented into consumables, sample
preparation, platforms & services for platforms, and sequencing services.
The sample preparation segment is further divided into end repair, A-tailing
& size selection, quality control, library preparation & target
enrichment, and DNA fragmentation. Other sub-segmentations have been mentioned
and expounded on in the report.
Applications of next-generation sequencing
include genetic screening, drug discovery, diagnostics, agriculture &
animal research, and others.
End-users of next-generation sequencing
include hospitals & clinics, academic institutes & research centers,
pharmaceutical & biotechnology companies, and other end-users.
Regional Analysis
The global next
generation sequencing market research Report is segmented into key regions
which include the Americas, Asia Pacific, Europe, and the Middle East &
Africa. North America in the Americas region is slated to lead the market with the
largest share due to the high competition between market players in the region
as well as the rising demand for next-gen sequencing in the healthcare sector
of developed economies such as the US and Canada. Moreover, the presence of a
significant healthcare sector in the region combined with growing investments
in healthcare toward the development of therapies for chronic diseases will
push growth during the forecast period.
The European region has the second largest
market due to the significant R&D activities that take place in the region
with regards to various fields including healthcare. The presence of pioneering
next-gen sequencing technology market players are expected to make an impact on
the market. However, growth here is restrained due to regulations and
fragmentation of the market across Europe.
Key Players
Oxford Nanopore Technologies, Ltd., BGI,
Pacific Biosciences of California, Inc., PerkinElmer, QIAGEN N. V., Eurofins
Scientific, Agilent Technologies, Macrogen Inc, Illumina, Inc., and Thermo
Fisher Scientific, Inc. are among the notable market players that have been
included in MRFR’s competition tracking of the global next generation
sequencing market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Wall